We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+23.8%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$376M
AUM Growth
+$23.8M
Cap. Flow
-$13.2M
Cap. Flow %
-3.51%
Top 10 Hldgs %
36.6%
Holding
101
New
12
Increased
44
Reduced
25
Closed
20

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$9.17M
2
PCVX icon
Vaxcyte
PCVX
+$6.2M
3
UTHR icon
United Therapeutics
UTHR
+$4.65M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$4.54M
5
BIIB icon
Biogen
BIIB
+$4.3M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$11.2M
2
WAT icon
Waters Corp
WAT
+$5.96M
3
RCM
R1 RCM Inc. Common Stock
RCM
+$5.16M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$4.24M
5
IQV icon
IQVIA
IQV
+$4.02M

Sector Composition

Rank Sector Weight
1 Healthcare 98.13%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGO
101
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
– –
-189,193
Closed -$2.85M
1 2 3 4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Parkman Healthcare Partners held 101 positions worth $376M, up 6.8% from $352M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parkman Healthcare Partners withdrew a net $13.2M in Q4 2022, closing 20 positions and reducing 25 holdings. Its most notable exit was CVS Health, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 96% a quarter earlier, followed by Industrials.

Against the trend, Parkman Healthcare Partners opened a new position in Humana worth $8.93M.

  • Parkman Healthcare Partners's largest Q4 2022 buy was Humana: 17,439 shares worth $8.93M.
  • Parkman Healthcare Partners added most to United Therapeutics in Q4 2022, an estimated $4.65M increase.
  • Parkman Healthcare Partners's biggest Q4 2022 reduction was Waters Corp, cutting an estimated $5.96M.
  • Parkman Healthcare Partners fully exited CVS Health in Q4 2022, selling an estimated $11.2M.
  • Parkman Healthcare Partners's ten largest holdings make up 37% of its $376M portfolio in Q4 2022.
  • Parkman Healthcare Partners opened 12 new positions and closed 20 in Q4 2022.
  • Parkman Healthcare Partners's portfolio value rose 6.8% quarter-over-quarter to $376M.

Based on Parkman Healthcare Partners's 13F filing for Q4 2022, filed 13 Feb 2023.